Patent Assignment
Reel/Frame 023861/0293
Change of Name
Recorded: 2010-01-28
Pages: 29
Assignor
MERCK & CO., INC.
Executed: 2009-11-02
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties
(205)
Homoerythromycin a Derivatives Modified at the 4"-and 8A-Positions
Patent:
5,985,844 →
Application:
07/855,242 →
Antibitotic Synthesis
Patent:
5,998,612 →
Application:
07/898,348 →
Method for Increasing Production of Disulfide Bonded Recombinant Proteins by Saccharomyces Cerevisiae
Patent:
6,291,205 →
Application:
07/901,713 →
Human Neurokinin-3 Receptor
Patent:
6,258,943 →
Application:
08/090,369 →
Vascular Endothelial Cell Growth Factor C Subunit
Patent:
5,994,300 →
Application:
08/124,259 →
Automated Analysis Equipment and Assay Method for Detecting Cell Surface Protein Function Using Same
Patent:
6,127,133 →
Application:
08/229,150 →
Method of Prevention of Prostatic Carcinoma with 17 Beta-N-Monosubstituted-Carbamoyl-4-Aza-5-Alpha-Androst-1-En-3-Ones
Patent:
6,268,376 →
Application:
08/364,072 →
Cation-Based Bioassay Using Human Metabotropic Glutamate Receptors
Patent:
6,001,581 →
Application:
08/367,264 →
Thermodynamically Stable Crystal Form of 4"-Deoxy-4"-Epi-Methylamino Avermectin B1A/B1B Benzoic Acid Salt and Processes for Its Preparation
Patent:
6,486,195 →
Application:
08/376,318 →
Method for Alleviating Varicella Related Post-Herpetic Neuralgia
Patent:
5,997,880 →
Application:
08/419,223 →
Automated Assays and Methods for Detecting and Modulating Cell Surface Protein Function
Patent:
6,057,114 →
Application:
08/434,511 →
Process of Synthesizing Binaphthyl Derivatives
Patent:
6,333,435 →
Application:
08/443,616 →
Human Calcium Channel Compositions and Methods
Patent:
6,096,514 →
Application:
08/450,562 →
Method of Treatment for Prostatic Cancer
Patent:
5,994,362 →
Application:
08/459,063 →
Dna and Mrna Encoding an A4 Subunit of Human Neuronal Nicotinic Acetylcholine Recptor and Cells Transformed with Same
Patent:
6,022,704 →
Application:
08/467,574 →
Assay for Marker of Human Polymorphonuclear Leukocyte Elastase Activity
Patent:
6,124,107 →
Application:
08/469,141 →
Capped Synthetic Rna, Analogs, and Aptamers
Patent:
6,111,095 →
Application:
08/480,068 →
Human N-Methyl-D-Aspartate Receptor Type 1 Subunits, Dna Encoding Same and Uses Therefor
Patent:
6,033,865 →
Application:
08/480,474 →
Human Neuronal Nicotinic Acetylcholine Receptor Alpha 6 Beta 3 Nucleic Acid
Patent:
6,485,967 →
Application:
08/484,722 →
Vascular Endothelial Cell Growth Factor C Subunit
Patent:
6,140,073 →
Application:
08/586,039 →
Human Neuronal Nicotinic Acetylcholine Receptor Compositions and Methods Employing Same
Patent:
6,524,789 →
Application:
08/660,451 →
Inhibitors of Farnesyl-Protein Transferase
Patent:
6,500,841 →
Application:
08/716,260 →
Histone Deacetylase as Target for Antiprotozal Agents
Patent:
6,110,697 →
Application:
08/716,978 →
Treatment of Macular Edema
Patent:
6,046,223 →
Application:
08/806,866 →
Leptin Assay
Patent:
6,007,998 →
Application:
08/837,635 →
Automated Analysis Equipment and Assay Method for Detecting Cell Surface Protein and/or Cytoplasmic Receptor Function Using Same
Patent:
6,372,183 →
Application:
08/870,537 →
Synthetic HPV6/11 Hybrid L1 Dna Encoding Human Papillomavirus Type 11 L1 Protein
Patent:
6,159,729 →
Application:
08/913,462 →
Sordarin Derivatives
Patent:
6,040,463 →
Application:
08/936,462 →
Human N-Methyl-D-Aspartate Receptor Subunits, Nucleic Acids Encoding Same and Uses Therefor
Patent:
6,111,091 →
Application:
08/940,086 →
2-(1H-4(5)-Imadazoyl) Cyclopropyl Compounds
Patent:
5,990,317 →
Application:
08/945,915 →
1H-4950-Substituted Imidazole Derivatives
Patent:
6,166,060 →
Application:
08/948,801 →
Human Calcium Channel Beta-4 Subunits
Patent:
6,090,623 →
Application:
08/949,386 →
Method for Large Scale Plasmid Purification
Patent:
6,197,553 →
Application:
08/952,428 →
Convergent Process for the Preparation of a Growth Hormone Secretagogue
Patent:
6,046,333 →
Application:
08/955,124 →
Capped Synthetic Rna, Analogs and Aptamers
Patent:
6,369,208 →
Application:
08/973,137 →
Calcium Channel Compositions and Methods
Patent:
6,528,630 →
Application:
08/984,709 →
2-(1H-4(5)-Imidazoyl) Cyclopropyl Derivatives
Patent:
6,008,240 →
Application:
08/991,030 →
A Nucleic Acid Encoding Rat Galanin Receptor GALR2
Patent:
6,287,855 →
Application:
08/993,088 →
Method for Reducing Mortality with an Angiotensin Ii Antagonist
Patent:
6,201,002 →
Application:
09/003,159 →
Integrin Antagonists
Patent:
6,017,925 →
Application:
09/006,626 →
Thiazole Benzenesulfonamides as B3 Agonists for Treatment of Diabetes and Obesity
Patent:
6,011,048 →
Application:
09/007,363 →
Method of Synergistic Treatment for Benign Prostatic Hyperplasia
Patent:
6,046,183 →
Application:
09/027,105 →
4-Azasteroids for Treatment of Hyperandrogenic Conditions
Patent:
6,001,844 →
Application:
09/029,926 →
Welding Process
Patent:
6,009,691 →
Application:
09/030,417 →
Somatostatin Agonists
Patent:
6,057,338 →
Application:
09/053,244 →
Somatostatin Agonists
Patent:
6,063,796 →
Application:
09/053,299 →
Somatostatin Agonists
Patent:
6,025,372 →
Application:
09/053,373 →
4-Oxa and 4-Thia Steroids
Patent:
5,998,464 →
Application:
09/065,112 →
Wet Granulation Formulation of a Growth Hormone Secretagogue
Patent:
6,123,964 →
Application:
09/066,469 →
Combination Therapy for the Prevention and Treatment of Osteoporosis
Patent:
6,043,026 →
Application:
09/071,211 →
Efficient Enantioselective Addition Reaction Using an Organozinc Reagent
Patent:
6,015,926 →
Application:
09/075,476 →
Growth Hormone Secretagogue Receptor Family
Patent:
6,531,314 →
Application:
09/077,674 →
Cholesterol-Lowering Therapy
Patent:
6,180,660 →
Application:
09/078,087 →
Human Adenosine Receptors
Patent:
6,166,181 →
Application:
09/080,704 →
Sodium Alendronate Preparation for Local Administration
Patent:
6,008,206 →
Application:
09/086,173 →
Polysaccharide Precipitation Process
Patent:
6,410,025 →
Application:
09/088,381 →
Stabilized Carbapenem Intermediates and Improved Process for Carbapenem Synthesis
Patent:
6,180,783 →
Application:
09/093,813 →
Human Receptor Tyrosine Kinase, Kdr
Patent:
6,204,011 →
Application:
09/098,707 →
Process for Synthesizing Carbapenem Side Chain Intermediates
Patent:
6,063,931 →
Application:
09/106,297 →
Method of Treating Diabetes and Related Disease States
Patent:
6,020,382 →
Application:
09/117,654 →
Anhydrous Alendronate Monosodium Salt Formulations
Patent:
6,008,207 →
Application:
09/133,200 →
Method for Inhibiting Bone Resorption
Patent:
5,994,329 →
Application:
09/134,214 →
Method for Inhibiting Bone Resortion
Patent:
6,015,801 →
Application:
09/134,215 →
Estrogen Receptor
Patent:
6,222,015 →
Application:
09/139,617 →
Large Scale Affinity Chromatography of Macromolecules
Patent:
6,372,425 →
Application:
09/140,201 →
Dna Molecules Encoding Human Nuclear Receptor Proteins
Patent:
6,054,295 →
Application:
09/141,000 →
Dry Mix Formulation for Bisphosphonic Acids
Patent:
6,090,410 →
Application:
09/141,782 →
Immunization Aghainst Streptococcus Pneumoniae Using Conjugated and Unconjugated Pneumoccocal Polysaccharide Aaccines
Patent:
6,224,880 →
Application:
09/145,661 →
9A-Azalides as Veterinary Antimicrobal Agetns
Patent:
6,054,434 →
Application:
09/149,940 →
Long Acting Injectable Formulations Containing Hydrogenated Castor Oil
Patent:
6,174,540 →
Application:
09/152,775 →
Process for Making Diaryl Pyridines Useful as Cox-2-Inhibitors
Patent:
6,040,450 →
Application:
09/153,405 →
Carbapenem Anitibacterial Compounds, Compositions Containing Such Compounds and Methods of Treatment
Patent:
6,140,318 →
Application:
09/168,622 →
Omeprazole Process and Compositions Thereof
Patent:
6,166,213 →
Application:
09/169,231 →
Method of Improved Mixing of a Varicella-Infected Cell Culture in Roller Bottles
Patent:
6,251,653 →
Application:
09/178,687 →
Method of Improved Mixing in Roller Bottles
Patent:
6,096,544 →
Application:
09/178,974 →
Compositions for a Once a Day Treatment of Cyclooxygenase-2 Mediated Diseases
Patent:
6,063,811 →
Application:
09/180,647 →
Somatostatin Agonists
Patent:
6,117,880 →
Application:
09/181,590 →
Human Glycine Transporter Type 2
Patent:
6,416,975 →
Application:
09/191,468 →
Conjugates Useful in the Treatment of Prostate Cancer
Patent:
6,174,858 →
Application:
09/193,365 →
Method for Treating Attention Deficit Disorder
Patent:
6,121,261 →
Application:
09/196,487 →
Integrin Receptor Antagonists
Patent:
6,017,926 →
Application:
09/212,079 →
Integrin Receptor Antagonists
Patent:
6,048,861 →
Application:
09/212,082 →
Integrin Receptor Antagonists
Patent:
6,066,648 →
Application:
09/212,123 →
Polymorphic Form of a Tachykinin Receptor Antagonist
Patent:
6,096,742 →
Application:
09/212,511 →
Arylthiazolidinedione Derivatives
Patent:
6,008,237 →
Application:
09/213,542 →
Alteration of Circadian Rhythmicity with a Tachykinin Antagonist
Patent:
6,034,105 →
Application:
09/216,194 →
Dna Pharmaceutical Formulations Comprising Citrate or Triethanolamine and Combinations Thereof
Patent:
6,387,695 →
Application:
09/218,590 →
Efficient Synthesis of a 1,4-Dihydro-2H-3,1-Benzoxazin-2-One
Patent:
6,114,569 →
Application:
09/224,923 →
Novel Chiral Bisphosphines
Patent:
6,043,387 →
Application:
09/243,859 →
Morpholine and Thiomorpholine Tachykinin Receptor Antagonists
Patent:
6,048,859 →
Application:
09/251,190 →
Transgenic Animal Lacking Native Amyloid Precursor Protein
Patent:
6,187,992 →
Application:
09/266,475 →
Nodulisporic Acid Derivatives
Patent:
6,221,894 →
Application:
09/269,010 →
Sulfurpentafluorophenylpyrazoles for Controlling Ectoparasitic Infestations
Patent:
6,136,838 →
Application:
09/271,092 →
Process for the Preparation of Leukotriene Antagonists
Patent:
6,320,052 →
Application:
09/274,062 →
Methods of Treating or Preventing Cardiac Arrhythmia
Patent:
6,214,809 →
Application:
09/284,704 →
Methods of Treating or Preventing Cardiac Arrhythmia
Patent:
6,214,810 →
Application:
09/284,705 →
Histone Deacetylase as Target for Antiprotozoal Agents
Patent:
6,428,983 →
Application:
09/296,834 →
Process for Synthesizing Cox-2 Inhibitors
Patent:
6,040,319 →
Application:
09/298,127 →
Bradykinin B1 Receptor Antibodies
Patent:
6,307,027 →
Application:
09/307,912 →
Method for Treating or Preventing Chronic Nonbacterial Prostatitis and Prostatodynia
Patent:
6,054,455 →
Application:
09/313,002 →
Pesticidal Formulation
Patent:
6,387,388 →
Application:
09/318,111 →
Formulations of Recombinant Papillomavirus Vaccines
Patent:
6,280,740 →
Application:
09/331,290 →
Antidiabetic Agents Based on Aryl and Heteroarylacetic Acids
Patent:
6,160,000 →
Application:
09/331,512 →
Process for Synthesizing Carbapenem Side Chain Intermediates
Patent:
6,060,607 →
Application:
09/334,398 →
Tricyclic Compounds
Patent:
6,048,869 →
Application:
09/360,266 →
Integrin Receptor Antagonists
Patent:
6,040,311 →
Application:
09/362,528 →
Rotavirus Vaccine Formulations
Patent:
6,403,098 →
Application:
09/366,616 →
Method for Treating or Preventing Psychosomatic Disorders
Patent:
6,232,311 →
Application:
09/371,394 →
Integrin Receptor Antagonists
Patent:
6,090,944 →
Application:
09/371,444 →
Method for Preventing Zoster or Alleviating Varicella Related Post-Herpetic Neuralgia
Patent:
6,214,354 →
Application:
09/372,535 →
Human N-Methyl-D-Aspartate Receptor Subnits, Nucleic Acids Encoding Same and Uses Therefor
Patent:
6,521,413 →
Application:
09/386,123 →
Enhancement of Return to Independent Living Status with a Growth Hormone Secretagogue
Patent:
6,194,402 →
Application:
09/386,177 →
Omeprazole Process and Compositions Thereof
Patent:
6,147,103 →
Application:
09/387,945 →
Method for Inhibiting Bone Resorption
Patent:
6,432,932 →
Application:
09/388,659 →
Recovery of Iodide from Chemical Process Wastewater
Patent:
6,379,556 →
Application:
09/394,325 →
Radiolabeled Neurokinin-1 Receptor Antagonists
Patent:
6,241,964 →
Application:
09/407,822 →
Heterocyclic Potassium Channel Inhibitors
Patent:
6,303,637 →
Application:
09/422,500 →
Dry Mix Formulation for Bisphosphonic Acids
Patent:
6,194,004 →
Application:
09/432,859 →
Sprio-Indolines as Y5 Receptor Antagonists
Patent:
6,191,160 →
Application:
09/436,120 →
Cannula Operated Pinch Valve
Patent:
6,461,345 →
Application:
09/436,416 →
Histone Deacetylase as Target for Antiprotozoal Agents
Patent:
6,068,987 →
Application:
09/443,003 →
Targeted Methods of Drug Screening Using Co-Culture Methods
Patent:
6,518,035 →
Application:
09/454,889 →
Polymorphic Form of a Tachykinin Receptor Antagonist
Patent:
6,229,010 →
Application:
09/458,168 →
Human Metabotropic Glutamate Receptors, Nucleic Acids Encoding Same and Uses Thereof
Patent:
6,485,919 →
Application:
09/459,715 →
Omeprazole Process and Compositions Thereof
Patent:
6,191,148 →
Application:
09/461,605 →
Method for Measuring Human Neurokinin-3 Receptor Ligand Binding
Patent:
6,348,330 →
Application:
09/482,971 →
Human receptor tyrosine kinase, kdr
Patent:
6,359,115 →
Application:
09/483,539 →
Process for Synthesizing Carbapenem Antibiotics
Patent:
6,504,027 →
Application:
09/487,044 →
Human papillomavirus vaccine formulations
Patent:
6,251,678 →
Application:
09/496,812 →
9A-Azalides as Veterinary Antimicrobial Agents
Patent:
6,339,063 →
Application:
09/508,489 →
Pharmaceutical composition containing proton pump inhibitors
Patent:
6,316,481 →
Application:
09/510,312 →
Inhibitors of prenyl-protein transferase
Patent:
6,376,496 →
Application:
09/516,756 →
3-Alkyl Substituted Pyrrolidine Modulators of Chemokine Receptor Activity
Patent:
6,489,354 →
Application:
09/516,771 →
tyrosine kinase inhibitors
Patent:
6,245,759 →
Application:
09/519,780 →
DNA encoding human papillomavirus type 6a
Patent:
6,290,965 →
Application:
09/521,526 →
Method for treating pediculosis capitis infestation
Patent:
6,262,031 →
Application:
09/523,335 →
Human Papilloma virus vaccine with disassembled and reassembled virus-like particles
Patent:
6,245,568 →
Application:
09/524,624 →
Isoforms of Mouse Serotonin 5-HT2C Recptor
Patent:
6,495,665 →
Application:
09/526,309 →
Morpholine and thiomorpholine tachykinin receptor antagonists
Patent:
6,235,735 →
Application:
09/526,843 →
Pyrrolidine Modulators of Chemokine Receptor Activity
Patent:
6,498,161 →
Application:
09/543,019 →
Estrogen Receptor
Patent:
6,458,551 →
Application:
09/561,741 →
Compounds Having Cytokine Inhibitory Activity
Patent:
6,492,516 →
Application:
09/564,272 →
Substituted piperidines as melanocortin-4 receptor agonists
Patent:
6,350,760 →
Application:
09/585,111 →
Pyrazinone Thrombin Inhibitors
Patent:
6,455,532 →
Application:
09/585,112 →
Cyclopentyl Modulators of Chemokine Receptor Activity
Patent:
6,506,777 →
Application:
09/589,972 →
N-Cyclopentyl Modulators of Chemokine Receptor Activity
Patent:
6,472,410 →
Application:
09/590,318 →
Cyclopentyl Modulators of Chemokine Receptor Activity
Patent:
6,432,981 →
Application:
09/590,484 →
Cyclopentyl Modulators of Chemokine Receptor Activity
Patent:
6,500,844 →
Application:
09/590,487 →
N-cyclopentyl modulators of chemokine receptor activity
Patent:
6,358,979 →
Application:
09/590,750 →
Nucleotide Encoding Humangalanin RECEPTOR3 (GALR3)
Patent:
6,511,827 →
Application:
09/595,549 →
Amido Spiropiperidines Promote the Release of Growth Hormone
Patent:
6,420,376 →
Application:
09/614,193 →
Stablized human papillomavirus formulations
Patent:
6,358,744 →
Application:
09/624,482 →
1H-4(5)-Substituted Imidazole Derivatives
Patent:
6,448,282 →
Application:
09/631,189 →
Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
Patent:
6,469,142 →
Application:
09/648,797 →
Radiolabeled Farnesyl-Protein Transferase Inhibitors
Patent:
6,458,935 →
Application:
09/668,637 →
Integrin Receptor Antagonists
Patent:
6,413,955 →
Application:
09/677,677 →
Novel Process for Making Human Papillomavirus Virus-Like Particles with Improved Properties
Patent:
6,436,402 →
Application:
09/684,233 →
Apparatus for Gripping Microplates
Patent:
6,449,827 →
Application:
09/686,645 →
Amide derivatives as Beta 3 Agonists
Patent:
6,291,491 →
Application:
09/689,169 →
Tyrosine kinase inhibitors
Patent:
6,306,874 →
Application:
09/690,598 →
Tyrosine Kinase Inhibitors
Patent:
6,479,512 →
Application:
09/690,602 →
Cyclic Amine Modulators of Chemokine Receptor Activity
Patent:
6,476,054 →
Application:
09/690,622 →
Combination Therapy for Treating, Preventing, or Reducing the Risks Associated with Acute Coronary Ischemic Syndrome and Related Conditions
Patent:
6,511,968 →
Application:
09/694,212 →
Antidiabetic Agents Based on Aryl and Heteroarylacetic Acids
Patent:
6,515,015 →
Application:
09/695,009 →
Anticoccidial compounds
Patent:
6,384,052 →
Application:
09/709,959 →
Diaryl piperidyl pyrrole derivatives as antiprotozoal agents
Patent:
6,291,480 →
Application:
09/710,147 →
Process for making diaryl pyridines useful as cox-2 inhibitors
Patent:
6,369,275 →
Application:
09/715,736 →
Process and Intermediates to a Tetrahydro-(1,8)- Naphthyridine
Patent:
6,423,845 →
Application:
09/718,139 →
Process for the Synthesis of Carbapenem Intermediates, and Compounds Produced
Patent:
6,489,471 →
Application:
09/719,503 →
Polymorphic, Amorphous and Hydrated Forms of 5-Chloro-3-(4-Methanesulfonylphenyl)-6'- Methyl-[2,3']Bipyridinyl
Patent:
6,441,002 →
Application:
09/724,522 →
Therapeutic Polymorphs of a Gaba-a Alpha-5 Inverse Agonist and Pamoate Formulations of the Same
Inhibitors of Prenyl-Protein Transferase
Alpha V Integrin Receptor Antagonists
Thrombin Receptor Antagonists
Spiropiperidine Derivatives as Melanocortin Receptor Agonists
Tyrosine Kinase Inhibitors
4-Alkyl Piperidinyl Pyrrolidine Modulators of Chemokine Receptor Activity
High Throughput Screening by Measurement of Intracellular Calcium Levels
Patent:
6,514,709 →
Application:
09/805,285 →
Spiropiperidine Derivatives as Melanocortin Receptor Agonists
Patent:
6,472,398 →
Application:
09/812,339 →
Method for Inhibiting Bone Resorption
Substituted Piperidines as Melanocortin Receptor Agonists
Process for Preparing 3-Hydroxymethyl-4-(Aryl or Heterocyclic)-Cyclopentanones
Process for Formulation of Antibiotic Compounds
Polymorphic Form of a Tachykinin Receptor Antagonist
2-Cyclohexyl Imidazopyridine Nmda/NR2B Antagonists
Substituted Cyclic Amidine Derivatives as Inhibitors of Cell Adhesion
5-Chloro-3-(4-Methanesulfonylphenyl)-6'-Methyl-[2,3']Bipyridinyl in Pure Crystalline Form and Process for Synthesis
Melanocortin receptor agonists
Pyrazinone Thrombin Inhibitors
Method of Prevention of Prostatic Carcinoma with 17BETA-N-Monosubstituted-Carbamoyl-4-Aza-5ALPHA-Androst-1-En-3-Ones
Process for the Synthesis of (2R, 2-Alpha-R) -4-Benzyl-2-[1- (3,5-Bis (Trifluoromethyl) Phenyl) Ethoxy] -1,4-Oxazine-3-One
Process for Preparing Acetonides
Npy Y5 Receptor Antagonists
Nonacyclic nodulisporic acid derivatives
Process for Adsorption of Mercury from Gaseous Streams
N-Substituted Indoles Useful in the Treatment of Diabetes
Thrombin Inhibitors
Modulators of CCR5 Chemokine Receptor Activity
Pyrrolidine Modulators of CCR5 Chemokine Receptor Activity
Prevention or Treatment of Insomina with a Neurokinin-1 Receptor Antagonist
Arylthiazolidinedione Derivatives
Dry Mix Formulation for Bisphosphonic Acids
Method of Treatment with a Combination of a PDE4 Inhibitor and a Leukotriene Antagonist
Novel Crystalline Forms of an Integrin Receptor Antagonist
Thrombin Inhibitors
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name
Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Confirmatory License
Jan 24, 2018
From: UNIVERSITY OF COLORADO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045134/0826 →
Confirmatory License
Jul 23, 2018
From: CU INNOVATIONS
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 046431/0587 →